<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-QUA-C-UNDP-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>QMJ C - Oceania - Multicountry Western Pacific (01-Jul-2015-31-Dec-2017)</narrative>
    </title>
    <description type="1">
      <narrative>Multicountry Western Pacific, TB/HIV, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: To halt the spread of HIV among the population of the Western Pacific and maintain HIV incidence rates below 0.1 percent annually in the 2015-2017 period; To promote universal and equitable access to quality diagnosis and appropriate treatment of TB, MDR-TB, TB/DM and TB/HIV patients across 11 Pacific Island Countries; To reduce AIDS-related mortality by strengthening HIV case finding and case management; To reduce the prevalence, incidence and mortality from all forms of TB in the 11 Pacific Island Countries, thereby contributing to the post-2015 global TB strategy. Objectives: Objective 1: Increase coverage of HIV-prevention services, with a special focus on key populations and other vulnerable populations; Objective 2: Strengthen coverage and quality of treatment, care and support for PLHIV, with special attention for adherence; Objective 3: Improve and expand use of strategic information to inform policy, programming, research and address structural barriers; Objective 4: To provide early rapid and quality diagnosis of TB, MDR-TB, TB/DM and TB/HIV with specific focus on screening and diagnosis in selected and prioritized hard to reach, vulnerable groups across 11 PICs; Objective 5: To sustain high quality treatment for all forms of TB including drug‐resistant TB and HIV related TB with patient support; Objective 6: To prevent TB through diagnosis and treatment of latent TB infection for high risk groups and scaling up of infection control measures.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="QUA-C-UNDPP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2015-07-01" />
    <activity-date type="2" iso-date="2015-07-01" />
    <activity-date type="3" iso-date="2017-12-31" />
    <activity-date type="4" iso-date="2017-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Sandra Irbe</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>sandra.irbe@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="3" />
    <recipient-region code="MCWP" vocabulary="99" vocabulary-uri="https://fetch.theglobalfund.org/v5/odata/geographies" percentage="100">
      <narrative>Multicountry Western Pacific</narrative>
    </recipient-region>
    <sector vocabulary="1" code="13040" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="1727d1ce-d80c-42cc-9fbb-d62b39f0986a">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-08-12" />
      <value currency="USD" value-date="2015-08-12">5821710.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d0d3b6bb-19af-4802-844b-f9be387b755d">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-08-13" />
      <value currency="USD" value-date="2015-08-13">3086356.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f3e9c506-2512-41c0-8217-d0f25ef59062">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-08-13" />
      <value currency="USD" value-date="2015-08-13">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="999237e4-194e-47d7-b66a-ba65ba212c3a">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-12-01" />
      <value currency="USD" value-date="2015-12-01">1838306.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="886c5779-31b0-4432-b5ee-4bfaf436bbc5">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-07-21" />
      <value currency="USD" value-date="2016-07-21">-872048.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b17dbe2f-2755-4065-a83d-09afe29c2606">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-07-21" />
      <value currency="USD" value-date="2016-07-21">6639510.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ab36aed5-735b-4488-a6bc-3244ebe1b2ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-07-22" />
      <value currency="USD" value-date="2016-07-22">3361005.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="948aa479-d823-4bb9-a263-87b65878f33d">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-10-07" />
      <value currency="USD" value-date="2016-10-07">1108843.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8e99f4ac-e145-4d0b-8abd-7375a97efedd">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-01-03" />
      <value currency="USD" value-date="2017-01-03">1141703.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="12cc0d1a-b920-4627-912e-dea50726d948">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-12" />
      <value currency="USD" value-date="2017-07-12">-1027959.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3298578b-c1f8-4c16-a0bf-dcbe138b5dc4">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-12" />
      <value currency="USD" value-date="2017-07-12">1328641.54</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d1bef855-ada7-438a-96e6-84668977e843">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-13" />
      <value currency="USD" value-date="2017-07-13">274171.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="781b60b2-4a5b-42a9-b7cc-b69324279bb0">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-10-24" />
      <value currency="USD" value-date="2017-10-24">1054470.54</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3de768ee-2cce-437a-b14b-c63b8cb778ad">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">25000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e41140e6-83c8-4648-a77f-bcfa8f1f504b">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-02-05" />
      <value currency="USD" value-date="2018-02-05">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/QUA-C-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>MDR-TB-other 1: Proportion of detected rifampicin-resistan TBt cases (RR-TB) and MDR-TB cases and that start treatment within four weeks from diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>MDR-TB-other 1: Proportion of detected rifampicin-resistan TBt cases (RR-TB) and MDR-TB cases and that start treatment within four weeks from diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="100">
          <comment>
            <narrative>Numerator: 1; Denominator: 1.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 2; Denominator: 2.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="100" />
          <actual value="33.3">
            <comment>
              <narrative>Numerator: 1; Denominator: 3.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="0">
          <comment>
            <narrative>Numerator: 0; Denominator: 58.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <actual value="20">
            <comment>
              <narrative>Numerator: 3; Denominator: 15.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 19; Denominator: 19.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
      </title>
      <description>
        <narrative>Module: PMTCT.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31">
          <comment>
            <narrative>Numerator: 1; Denominator: 15; Percentage: 6.7%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4; Denominator: 8; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6; Denominator: 9; Percentage: 66.7%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7; Denominator: 10; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1; Denominator: 1; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
      </title>
      <description>
        <narrative>Module: PMTCT.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31">
          <comment>
            <narrative>Numerator: 1; Denominator: 15; Percentage: 6.7%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4; Denominator: 8; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6; Denominator: 9; Percentage: 66.7%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7; Denominator: 10; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1; Denominator: 1; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women who know their HIV status</narrative>
      </title>
      <description>
        <narrative>Module: PMTCT.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women who know their HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="4.9">
          <comment>
            <narrative>Numerator: 1211; Denominator: 24700.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 7537; Denominator: 12561.</narrative>
            </comment>
          </target>
          <actual value="90.4">
            <comment>
              <narrative>Numerator: 7484; Denominator: 8280.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 8900; Denominator: 12714.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 10296; Denominator: 12871.</narrative>
            </comment>
          </target>
          <actual value="73.4">
            <comment>
              <narrative>Numerator: 15592; Denominator: 21227.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention programs for MSM and TGs.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="0">
          <comment>
            <narrative>Numerator: 0; Denominator: 7460.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="10">
            <comment>
              <narrative>Numerator: 772; Denominator: 7722.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="15">
            <comment>
              <narrative>Numerator: 1172; Denominator: 7814.</narrative>
            </comment>
          </target>
          <actual value="3.6">
            <comment>
              <narrative>Numerator: 281; Denominator: 7814.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Prevention programs for MSM and TGs.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="0">
          <comment>
            <narrative>Numerator: 0; Denominator: 7460.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="6.9">
            <comment>
              <narrative>Numerator: 529; Denominator: 7722.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="9.1">
            <comment>
              <narrative>Numerator: 710; Denominator: 7814.</narrative>
            </comment>
          </target>
          <actual value="2.1">
            <comment>
              <narrative>Numerator: 167; Denominator: 7814.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of antenatal care attendees tested for syphilis</narrative>
      </title>
      <description>
        <narrative>Module: Prevention programs for general population.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of antenatal care attendees tested for syphilis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="85.7">
          <comment>
            <narrative>Numerator: 23995; Denominator: 27998.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 24475; Denominator: 28138.</narrative>
            </comment>
          </target>
          <actual value="94.6">
            <comment>
              <narrative>Numerator: 7834; Denominator: 8280.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="89.6">
            <comment>
              <narrative>Numerator: 25464; Denominator: 28420.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="92.3">
            <comment>
              <narrative>Numerator: 26492; Denominator: 28705.</narrative>
            </comment>
          </target>
          <actual value="75.1">
            <comment>
              <narrative>Numerator: 15944; Denominator: 21227.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="63.6">
          <comment>
            <narrative>Numerator: 7; Denominator: 11.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="63.6">
            <comment>
              <narrative>Numerator: 7; Denominator: 11.</narrative>
            </comment>
          </target>
          <actual value="72.7">
            <comment>
              <narrative>Numerator: 8; Denominator: 11.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="81.8">
            <comment>
              <narrative>Numerator: 9; Denominator: 11.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 11; Denominator: 11.</narrative>
            </comment>
          </target>
          <actual value="81.8">
            <comment>
              <narrative>Numerator: 9; Denominator: 11.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 899.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 475.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 514.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 502.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 531.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 920; Percentage: 120%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 336.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 181.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 247.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 196.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 218.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 417; Percentage: 120%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="85.1">
          <comment>
            <narrative>Numerator: 286; Denominator: 336.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="85.1">
            <comment>
              <narrative>Numerator: 154; Denominator: 181.</narrative>
            </comment>
          </target>
          <actual value="85.4">
            <comment>
              <narrative>Numerator: 304; Denominator: 356.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="86.2">
            <comment>
              <narrative>Numerator: 169; Denominator: 196.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="86.7">
            <comment>
              <narrative>Numerator: 189; Denominator: 218.</narrative>
            </comment>
          </target>
          <actual value="89.6">
            <comment>
              <narrative>Numerator: 361; Denominator: 403.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="77.8">
          <comment>
            <narrative>Numerator: 7; Denominator: 9.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="77.8">
            <comment>
              <narrative>Numerator: 7; Denominator: 9.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="88.9">
            <comment>
              <narrative>Numerator: 8; Denominator: 9.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="88.9">
            <comment>
              <narrative>Numerator: 8; Denominator: 9.</narrative>
            </comment>
          </target>
          <actual value="122.2">
            <comment>
              <narrative>Numerator: 11; Denominator: 9.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="85">
          <comment>
            <narrative>Numerator: 764; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="85.1">
            <comment>
              <narrative>Numerator: 404; Denominator: 475.</narrative>
            </comment>
          </target>
          <actual value="83.3">
            <comment>
              <narrative>Numerator: 720; Denominator: 864.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="86.1">
            <comment>
              <narrative>Numerator: 432; Denominator: 502.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 462; Denominator: 531.</narrative>
            </comment>
          </target>
          <actual value="86.8">
            <comment>
              <narrative>Numerator: 874; Denominator: 1007.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="56.6">
          <comment>
            <narrative>Numerator: 530; Denominator: 936.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target value="60" />
          <actual value="51.8">
            <comment>
              <narrative>Numerator: 266; Denominator: 514.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="65" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="70" />
          <actual value="61.7">
            <comment>
              <narrative>Numerator: 566; Denominator: 918.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 34; Denominator: 85; Percentage: 40%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 42; Denominator: 98; Percentage: 42.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 39.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 57; Denominator: 105; Percentage: 54.3%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 72; Denominator: 112; Percentage: 64.3%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 39; Denominator: 74; Percentage: 52.7%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-QUA-C-UNDP-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Multi-country Western Pacific (MWP) Integrated HIV/TB Program - Oceania - Multicountry Western Pacific (01-Jan-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Multicountry Western Pacific, TB/HIV, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: To halt the spread of HIV among the population of the Western Pacific and maintain HIV incidence rates below 0.1 percent annually; To reduce AIDS-related mortality by strengthening HIV case finding and case management; To reduce the prevalence, incidence and mortality from all forms of TB in the 11 Pacific Island Countries, thereby contributing to the post-2015 global TB strategy; To promote universal and equitable access to quality diagnosis and appropriate treatment of TB, MDR-TB, TB/DM and TB/HIV patients across 11 Pacific Island Countries. Objectives: Increase coverage of HIV-prevention services, with a special focus on key populations and other vulnerable populations; Strengthen coverage and quality of treatment, care and support for PLHIV, with special attention for adherence; To provide early rapid and quality diagnosis of TB, MDR-TB, TB/DM and TB/HIV with specific focus on screening and diagnosis in selected and prioritized hard to reach, vulnerable groups across 11 PICs; To sustain high quality treatment for all forms of TB including drug‐resistant TB and HIV related TB with patient support.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="QUA-C-UNDPP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-01-01" />
    <activity-date type="2" iso-date="2018-01-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Sandra Irbe</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>sandra.irbe@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="3" />
    <recipient-region code="MCWP" vocabulary="99" vocabulary-uri="https://fetch.theglobalfund.org/v5/odata/geographies" percentage="100">
      <narrative>Multicountry Western Pacific</narrative>
    </recipient-region>
    <sector vocabulary="1" code="12110" percentage="45.87">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="30.83">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="23.3">
      <narrative>HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="aed28580-8855-4e52-adf6-30c21552c473" percentage="0.27">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for MSM -&gt; Addressing stigma, discrimination and violence against MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7e4b93f2-44a8-439d-b8e5-143be7b5aa27" percentage="0.56">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for MSM -&gt; Behavioral interventions for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="761c4916-f454-41dd-9736-cb3d42a42d84" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for MSM -&gt; Community empowerment for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="d176d37a-ad2b-4b67-af1a-265e80bd5c10" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for MSM -&gt; Condoms and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="d96a15d6-37d6-45bb-8201-3ac2506d10da" percentage="0.65">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for TGs -&gt; Addressing stigma, discrimination and violence against TGs</narrative>
        </description>
      </budget-item>
      <budget-item code="dcb7435c-68dd-4f9b-a422-0fd44e268fc1" percentage="1.17">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for TGs -&gt; Behavioral interventions for TGs</narrative>
        </description>
      </budget-item>
      <budget-item code="87b9bb78-50f1-4b0c-b9c3-d106d6e6d5ba" percentage="0.86">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for TGs -&gt; Community empowerment for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="8624934e-6b17-4002-abb1-870176a890a6" percentage="1.3">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for TGs -&gt; Condoms and lubricant programming for TGs</narrative>
        </description>
      </budget-item>
      <budget-item code="baada981-4aeb-4243-8955-ccd921e4d1cd" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for TGs -&gt; HIV testing services for TGs</narrative>
        </description>
      </budget-item>
      <budget-item code="cac041bd-66b9-43df-a41c-2bb0a69b4c0b" percentage="0.86">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for TGs -&gt; Other intervention(s) for TGs</narrative>
        </description>
      </budget-item>
      <budget-item code="9fdc34c6-16d4-416e-a973-ca9e1d75da86" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Addressing stigma, discrimination and violence against sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="57d69675-36b7-4f3f-b9a0-87b556fdd5a3" percentage="0.46">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Behavioral interventions for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="d04e953f-7e8b-484b-9832-154d02d7784e" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Condoms and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="5069edaf-d26d-421b-ba0e-fdd19003aeef" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Other intervention(s) for sex workers and their clients</narrative>
        </description>
      </budget-item>
      <budget-item code="43040121-7c59-4d93-9b1a-708f68d30073" percentage="0.41">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
        </description>
      </budget-item>
      <budget-item code="925d8e7c-f7a1-4507-b75d-6e254720fa3f" percentage="0.05">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
        </description>
      </budget-item>
      <budget-item code="c720b257-8368-4aff-acdb-5fc2ba3b9530" percentage="1.33">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Community mobilization and norms change</narrative>
        </description>
      </budget-item>
      <budget-item code="7b633a41-191b-4d53-8194-b055cb83e3ef" percentage="1.59">
        <description>
          <narrative>HIV -&gt; Prevention programs for other vulnerable populations -&gt; Behavioral interventions for other vulnerable populations</narrative>
        </description>
      </budget-item>
      <budget-item code="d9070ac3-d819-49d5-b62c-22a5993753ae" percentage="0.43">
        <description>
          <narrative>HIV -&gt; Prevention programs for other vulnerable populations -&gt; Diagnosis and treatment of STIs and other sexual health services for other vulnerable populations</narrative>
        </description>
      </budget-item>
      <budget-item code="988b9b87-5045-47a3-bbed-86d8d8c92ad1" percentage="3.24">
        <description>
          <narrative>HIV -&gt; Prevention programs for other vulnerable populations -&gt; HIV testing services for other vulnerable populations</narrative>
        </description>
      </budget-item>
      <budget-item code="3f64e108-1cb3-4c05-951c-45ffbf713e6a" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Prevention programs for other vulnerable populations -&gt; Other intervention(s) for other vulnerable populations</narrative>
        </description>
      </budget-item>
      <budget-item code="13226ebb-f8c7-4f2d-8602-095b1223b89b" percentage="0.89">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
        </description>
      </budget-item>
      <budget-item code="71178700-eb1a-4054-9c6a-ba203ed39cef" percentage="5.89">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e53ba535-c657-45be-8818-ca510aadaba3" percentage="1.45">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Other intervention(s) for treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="5617b892-3d6e-42d5-8005-bd04d04e2f7e" percentage="0.84">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Prevention, diagnosis and treatment of opportunistic infections</narrative>
        </description>
      </budget-item>
      <budget-item code="c7d050d8-ddb8-42db-a948-04038ae9cd0f" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
        </description>
      </budget-item>
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="20.49">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="8.96">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="4cd90b50-0924-481f-b5a1-22b7305b5dbb" percentage="0.15">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="04ad0584-b1dd-4ef6-ac1e-dad3669a97d1" percentage="0.82">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="3e9642ae-693f-47d9-95b3-3cf2c3e2e170" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Other community responses and systems intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="2c00622f-0877-4553-993e-389582dbbfd1" percentage="1.56">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="043741b4-bd0a-492c-8759-b4cac0a50e64" percentage="4.34">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Other health information systems and M&amp;E intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="a917e4f1-a1df-4b72-a335-1d4b3db2d854" percentage="1.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain infrastructure and development of tools</narrative>
        </description>
      </budget-item>
      <budget-item code="054acddf-7eaa-4d8d-b6a4-97e7f6a59a1e" percentage="1.05">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Capacity building for health workers, including those at community level</narrative>
        </description>
      </budget-item>
      <budget-item code="6cc769f6-bf9e-46dd-90d8-d293fa8bc359" percentage="3.74">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Laboratory systems for disease prevention, control, treatment and disease surveillance</narrative>
        </description>
      </budget-item>
      <budget-item code="defb4ca5-d606-456a-a463-d4939ec51355" percentage="2.19">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Other service delivery intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="41e196cd-8e22-40d0-8d8e-595683020124" percentage="0.11">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service delivery infrastructure</narrative>
        </description>
      </budget-item>
      <budget-item code="adeac860-3310-4061-ad9b-f184f1a3105e" percentage="1.36">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Supportive policy and programmatic environment</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="0.23">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="0.63">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="8.28">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e6d6284e-9e23-498f-91ee-4393f4aa49a1" percentage="0.25">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="0.27">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="cbff055b-fbc0-468b-9604-e69b10cbd9dd" percentage="0.66">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="fbc19cfa-87a0-4ea9-b0f8-b510eb8eab13" percentage="6.53">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Other TB care and prevention intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="accfbf9b-023f-4bd8-b952-bf1cb13e8e9b" percentage="0.17">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="8.79">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="13c1e439-070b-4238-9903-7972703a027e" percentage="0.11">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="f6635c15-0555-4875-ac3c-f76851341d6a" percentage="1.57">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="210d51b7-40a1-4b35-b1fe-14cb15713360" percentage="0.15">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="07fd3a5f-c9c2-4bda-a47f-8b744b7fd95e" percentage="1.25">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Other TB/HIV intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="1.93">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">3770425.00</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">3055430.17</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">4542857.77</value>
    </budget>
    <capital-spend percentage="7.24" />
    <transaction ref="980f9d6a-150f-4c7e-89a9-7fe501e04822">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-01-10" />
      <value currency="USD" value-date="2018-01-10">6249262.97</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="069fa14a-b142-4221-8642-222a6cf77d68">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-11" />
      <value currency="USD" value-date="2018-01-11">1520506.88</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3219fb2a-202f-4f34-bc3e-33215097257c">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-03-27" />
      <value currency="USD" value-date="2018-03-27">936458.73</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dba9a263-1683-4af7-93f3-91aaec5695e0">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-07" />
      <value currency="USD" value-date="2018-05-07">25000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="073643e5-bbc9-45e7-ab05-9d41c179b084">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-07" />
      <value currency="USD" value-date="2018-08-07">717073.40</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d9aa874c-3b56-42ed-9cb0-9a0d99aa3cfc">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-04" />
      <value currency="USD" value-date="2018-10-04">856429.15</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="21b9e9c2-2a51-4c17-89e3-76d636831792">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-15" />
      <value currency="USD" value-date="2019-01-15">1243709.32</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0883054d-f6be-4e8e-9ee6-a2b963a3f5be">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-07" />
      <value currency="USD" value-date="2019-05-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9df5b39b-d86a-428d-a290-1f326d0a0d9d">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-07" />
      <value currency="USD" value-date="2019-05-07">-25000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0b4f47aa-15e3-45da-bd3e-1339c02627c1">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-05-09" />
      <value currency="USD" value-date="2019-05-09">975085.49</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3d281f47-868b-443c-91e8-99ec26174322">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-06-20" />
      <value currency="USD" value-date="2019-06-20">3120055.72</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ddc24275-d944-4e13-a81b-f0076ace94bb">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-07-25" />
      <value currency="USD" value-date="2019-07-25">240570.48</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="196d49b3-38ea-4b6a-bf60-96393dc230cc">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-11-08" />
      <value currency="USD" value-date="2019-11-08">746945.68</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a450635f-bc8a-4a4b-9ab4-a76a9ed6e644">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-18" />
      <value currency="USD" value-date="2020-02-18">1192983.26</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="14234dd1-7883-4aa3-a59a-cc7fd89b2eb6">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-14" />
      <value currency="USD" value-date="2020-04-14">939556.30</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="10860be5-e616-4640-84bd-6a994a1e6626">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-13" />
      <value currency="USD" value-date="2020-05-13">-50000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2afcc5bf-72de-4bc3-82b8-cc9c74790684">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-13" />
      <value currency="USD" value-date="2020-05-13">1650433.31</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d107b376-4468-404c-bec7-c7b74634d553">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-13" />
      <value currency="USD" value-date="2020-05-13">75000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2312ee48-a793-42de-bc26-10505eb3fb7f">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-11" />
      <value currency="USD" value-date="2020-06-11">50000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="454aae3b-e009-4fbf-b71b-3de2812b0bbf">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-11" />
      <value currency="USD" value-date="2020-06-11">-75000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7eaad7b5-7705-4e29-b241-c6c6cc50b7f5">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-16" />
      <value currency="USD" value-date="2020-06-16">208623.06</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cae5d8a0-d67d-45b5-8e1a-b70c53533e70">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-09-09" />
      <value currency="USD" value-date="2020-09-09">699445.25</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="712e865e-e2fa-4ed6-ad05-d1701ea63192">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-21" />
      <value currency="USD" value-date="2020-10-21">742365.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="51913214-45ee-45ed-b04b-43429d0d2afd">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-03" />
      <value currency="USD" value-date="2020-12-03">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dda50b46-acf9-483e-bda8-e55b685cc290">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-03-30" />
      <value currency="USD" value-date="2021-03-30">-25000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="QUA-C-UNDPP02-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">3770425.00</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for QUA-C-UNDPP02, Jan 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QUA-C-UNDPP02-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">3055429.85</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for QUA-C-UNDPP02, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QUA-C-UNDPP02-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">4179803.64</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for QUA-C-UNDPP02, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QUA-C-UNDPP02-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">129557.00</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for QUA-C-UNDPP02, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/QUA-C-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for MSM.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="0.58">
          <comment>
            <narrative>Numerator: 54; Denominator: 9284.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="7.25">
            <comment>
              <narrative>Numerator: 673; Denominator: 9284.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 665; Denominator: 665.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="11.15">
            <comment>
              <narrative>Numerator: 1035; Denominator: 9284.</narrative>
            </comment>
          </target>
          <actual value="15.9">
            <comment>
              <narrative>Numerator: 1472; Denominator: 9284.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="17.15">
            <comment>
              <narrative>Numerator: 1592; Denominator: 9284.</narrative>
            </comment>
          </target>
          <actual value="16.7">
            <comment>
              <narrative>Numerator: 1549; Denominator: 9284.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for MSM.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="0.25">
          <comment>
            <narrative>Numerator: 23; Denominator: 9284.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="3.11">
            <comment>
              <narrative>Numerator: 289; Denominator: 9284.</narrative>
            </comment>
          </target>
          <actual value="6">
            <comment>
              <narrative>Numerator: 561; Denominator: 9284.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="4.79">
            <comment>
              <narrative>Numerator: 445; Denominator: 9284.</narrative>
            </comment>
          </target>
          <actual value="12.5">
            <comment>
              <narrative>Numerator: 1160; Denominator: 9284.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="7.38">
            <comment>
              <narrative>Numerator: 685; Denominator: 9284.</narrative>
            </comment>
          </target>
          <actual value="10.6">
            <comment>
              <narrative>Numerator: 984; Denominator: 9284.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for TGs.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="0.45">
          <comment>
            <narrative>Numerator: 84; Denominator: 18569.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="7.24">
            <comment>
              <narrative>Numerator: 1345; Denominator: 18569.</narrative>
            </comment>
          </target>
          <actual value="5.1">
            <comment>
              <narrative>Numerator: 950; Denominator: 18569.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="11.15">
            <comment>
              <narrative>Numerator: 2070; Denominator: 18569.</narrative>
            </comment>
          </target>
          <actual value="11">
            <comment>
              <narrative>Numerator: 2046; Denominator: 18569.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="17.15">
            <comment>
              <narrative>Numerator: 3185; Denominator: 18569.</narrative>
            </comment>
          </target>
          <actual value="11.6">
            <comment>
              <narrative>Numerator: 2149; Denominator: 18569.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for TGs.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="0.33">
          <comment>
            <narrative>Numerator: 62; Denominator: 18569.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="5.36">
            <comment>
              <narrative>Numerator: 995; Denominator: 18569.</narrative>
            </comment>
          </target>
          <actual value="5">
            <comment>
              <narrative>Numerator: 937; Denominator: 18569.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="8.25">
            <comment>
              <narrative>Numerator: 1532; Denominator: 18569.</narrative>
            </comment>
          </target>
          <actual value="10.3">
            <comment>
              <narrative>Numerator: 1910; Denominator: 18569.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="12.69">
            <comment>
              <narrative>Numerator: 2357; Denominator: 18569.</narrative>
            </comment>
          </target>
          <actual value="11">
            <comment>
              <narrative>Numerator: 2043; Denominator: 18569.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for sex workers and their clients.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="1.36">
          <comment>
            <narrative>Numerator: 53; Denominator: 3904.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="7.25">
            <comment>
              <narrative>Numerator: 283; Denominator: 3904.</narrative>
            </comment>
          </target>
          <actual value="20">
            <comment>
              <narrative>Numerator: 781; Denominator: 3904.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="11.14">
            <comment>
              <narrative>Numerator: 435; Denominator: 3904.</narrative>
            </comment>
          </target>
          <actual value="35.1">
            <comment>
              <narrative>Numerator: 1369; Denominator: 3904.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="17.16">
            <comment>
              <narrative>Numerator: 670; Denominator: 3904.</narrative>
            </comment>
          </target>
          <actual value="29.9">
            <comment>
              <narrative>Numerator: 1167; Denominator: 3904.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for sex workers and their clients.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="1.43">
          <comment>
            <narrative>Numerator: 56; Denominator: 3904.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="6.89">
            <comment>
              <narrative>Numerator: 269; Denominator: 3904.</narrative>
            </comment>
          </target>
          <actual value="19.6">
            <comment>
              <narrative>Numerator: 767; Denominator: 3904.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="10.58">
            <comment>
              <narrative>Numerator: 413; Denominator: 3904.</narrative>
            </comment>
          </target>
          <actual value="34.9">
            <comment>
              <narrative>Numerator: 1364; Denominator: 3904.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="16.32">
            <comment>
              <narrative>Numerator: 637; Denominator: 3904.</narrative>
            </comment>
          </target>
          <actual value="29.9">
            <comment>
              <narrative>Numerator: 1167; Denominator: 3904.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9; Denominator: 9; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 10.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 11.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="1019" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="1253" />
          <actual value="985" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="1134" />
          <actual value="895" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="1232" />
          <actual value="776" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="84" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="86" />
          <actual value="86.2">
            <comment>
              <narrative>Numerator: 788; Denominator: 914.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="87" />
          <actual value="91">
            <comment>
              <narrative>Numerator: 899; Denominator: 988.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90" />
          <actual value="88.5">
            <comment>
              <narrative>Numerator: 715; Denominator: 808.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="86.89">
          <comment>
            <narrative>Numerator: 53; Denominator: 61.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="79">
            <comment>
              <narrative>Numerator: 58; Denominator: 73.</narrative>
            </comment>
          </target>
          <actual value="72.6">
            <comment>
              <narrative>Numerator: 53; Denominator: 73.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="88.57">
            <comment>
              <narrative>Numerator: 62; Denominator: 70.</narrative>
            </comment>
          </target>
          <actual value="80">
            <comment>
              <narrative>Numerator: 56; Denominator: 70.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="89.87">
            <comment>
              <narrative>Numerator: 71; Denominator: 79.</narrative>
            </comment>
          </target>
          <actual value="77.2">
            <comment>
              <narrative>Numerator: 61; Denominator: 79.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-QUA-C-UNDP-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Multi-country Western Pacific (MWP) Integrated HIV/TB Program - Oceania - Multicountry Western Pacific (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Multicountry Western Pacific, TB/HIV, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: To halt the spread of HIV among the population of the Western Pacific and maintain HIV incidence rates below 0.1 percent annually; To reduce AIDS-related mortality by strengthening HIV case finding and case management; To reduce the incidence and mortality from all forms of TB in the 11 Pacific Island Countries, thereby contributing to the post-2015 global TB strategy; To promote universal and equitable access to quality diagnosis and appropriate treatment of TB, MDR-TB, TB/DM and TB/HIV patients across 11 Pacific Island Countries. Objectives: Strengthening comprehensiveness and quality of HIV prevention, treatment and care service-delivery models with a view to programmatic sustainability; Strengthen resilience of community and health systems; To provide early rapid and quality diagnosis of TB, MDR-TB, TB/Diabetes and co-morbidities and TB/HIV with specific focus on screening and diagnosis in selected and prioritized hard to reach, vulnerable groups across 11 Pacific Island Countries; To sustain high quality treatment for all forms of TB including drug‐resistant TB and HIV related TB with patient support.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="QUA-C-UNDPP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Sandra Irbe</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>sandra.irbe@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="3" />
    <recipient-region code="MCWP" vocabulary="99" vocabulary-uri="https://fetch.theglobalfund.org/v5/odata/geographies" percentage="100">
      <narrative>Multicountry Western Pacific</narrative>
    </recipient-region>
    <sector vocabulary="1" code="12110" percentage="46.82">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="26.83">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="26.35">
      <narrative>HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="2f83940f-3956-46e3-aeb4-0a2b2ee56af3" percentage="0.52">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="f83bbdd0-a94f-473b-9cc3-ae8a59141348" percentage="2.26">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="8cc23209-2129-4c18-b058-a4c3a63b6ae4" percentage="0.04">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
        </description>
      </budget-item>
      <budget-item code="88657fe2-2942-4159-860a-af9e84e64238" percentage="15.15">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="e60fdd71-5159-45b8-b0e5-887e3c84eba3" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Community empowerment</narrative>
        </description>
      </budget-item>
      <budget-item code="4cda1636-6187-4ff6-8ed5-1fcceeb830bf" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Comprehensive sexuality education for AGYW and adolescent boys and young men (ABYM)</narrative>
        </description>
      </budget-item>
      <budget-item code="b0f7e056-b292-405c-81ee-0e3d059dde00" percentage="0.75">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Condom and lubricant programming</narrative>
        </description>
      </budget-item>
      <budget-item code="dca7e9d2-7860-49a4-8fb9-9fe629cd8d8c" percentage="0.04">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Interventions for young key populations</narrative>
        </description>
      </budget-item>
      <budget-item code="61bfa00d-5158-4201-9e12-b91bee129c91" percentage="0.24">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Pre-exposure prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="e2860998-43fe-4145-aabf-08302069b9f1" percentage="0.72">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Sexual and reproductive health services, including STIs</narrative>
        </description>
      </budget-item>
      <budget-item code="0597f88b-5b88-4b47-8d91-6f7889b4f36f" percentage="0.03">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
        </description>
      </budget-item>
      <budget-item code="9476a49e-917c-4607-b0d3-5ccee13653a6" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="336e2f1a-7395-4d59-b42e-5e9916975074" percentage="0.77">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
        </description>
      </budget-item>
      <budget-item code="b0eb178f-7923-4f1d-a0dc-04aed075b79a" percentage="4.53">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="582a5bc6-226b-4ea9-9391-54880da66119" percentage="0.93">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Prevention and management of co-infections and co-morbidities (Treatment, care and support)</narrative>
        </description>
      </budget-item>
      <budget-item code="62adfb99-3345-4b03-ad9f-89b544624a5b" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
        </description>
      </budget-item>
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="0.8">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="30.85">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="25710664-d25f-448a-9b94-5e4b210a97c6" percentage="1.52">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="e61e1ae8-85c6-488f-8a92-215981bf93a2" percentage="0.45">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="ea41b061-34f4-4f5f-b2d7-d7e7838c9c59" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Routine grant financial management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.99">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="0.43">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="0.35">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="5c6d2150-43bf-412f-a249-05dbaa402867" percentage="0.44">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="73afa0ce-d818-4bb2-adeb-c13f28c03a1f" percentage="1.09">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="86ab2998-11d1-439b-a3b8-c56ee091314c" percentage="0.1">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; Policy and planning for national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="2e70d708-2e0e-4a4b-8b70-9c06353b64eb" percentage="1.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Community health workers: Education and production</narrative>
        </description>
      </budget-item>
      <budget-item code="39d0b266-c33c-4b1e-83dd-a7f194e439b8" percentage="0.17">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Community health workers: In-service training</narrative>
        </description>
      </budget-item>
      <budget-item code="c60867f7-c15c-4000-9ba6-be0dfa8cd3e9" percentage="1.96">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Community health workers: Remuneration and deployment</narrative>
        </description>
      </budget-item>
      <budget-item code="c97057e4-6632-436b-804c-269b88172bc2" percentage="1.22">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Education and production of new health workers (excluding community health workers)</narrative>
        </description>
      </budget-item>
      <budget-item code="1b7258e5-95a1-4ad0-aa27-849d84eb27b3" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; In-service training (excluding community health workers)</narrative>
        </description>
      </budget-item>
      <budget-item code="a47ec95d-9737-4650-ba19-86db996b3cdd" percentage="3.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Remuneration &amp; deployment of existing/new staff (excluding community health workers)</narrative>
        </description>
      </budget-item>
      <budget-item code="fcefda7f-7f79-40d5-92ba-393c34a2616c" percentage="1.43">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Quality of care</narrative>
        </description>
      </budget-item>
      <budget-item code="0fa82570-990a-4ca3-98f1-4952587f8be1" percentage="0.25">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service delivery infrastructure</narrative>
        </description>
      </budget-item>
      <budget-item code="23a802a3-2312-4589-bbe9-62a7cf2c91d2" percentage="0.47">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="0.24">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="22851d66-f7e4-4cc5-950a-ad9cac3568a2" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="0.31">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="11.05">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="9afa836c-5fc6-4ff5-973e-19cb5f9bc599" percentage="0.68">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="1.26">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="0.05">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="0.24">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="7.18">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2a4026f0-ad81-4b0f-9cfb-c54a725ea0ea" percentage="0.53">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="3844a48b-ee6f-484c-866d-4d19de42ce72" percentage="0.35">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Community TB/HIV care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="f9ff8a94-1fc1-4acf-863f-a191df107ee9" percentage="0.16">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="2146ce4f-9254-4a2a-8be8-e14734ab53dc" percentage="1.88">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="d5851297-913c-4ce3-a373-c0915334727a" percentage="1.92">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="31f7c6af-8b6f-4289-90f3-c6f20f232eb7" percentage="0.94">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="0a35e9e6-4228-4dab-8282-e098299db9bf" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Treatment (TB/HIV)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">2415228.02</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">5014927.00</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">5325391.60</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">844638.88</value>
    </budget>
    <capital-spend percentage="13.66" />
    <transaction ref="1222e2c1-4366-414e-af14-c41882d3314f">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-20" />
      <value currency="USD" value-date="2021-01-20">5510952.44</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a3b2a758-d0d1-4590-b1e6-78d9faefd883">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-28" />
      <value currency="USD" value-date="2021-01-28">1070435.57</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="629a1bfe-f98b-49f0-8969-39b665f2a3b9">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-30" />
      <value currency="USD" value-date="2021-04-30">838350.54</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="63bfb1c4-256a-4710-a5f0-99cdfe153b89">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-01" />
      <value currency="USD" value-date="2021-07-01">1134035.10</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4a5d56d8-d08b-4f3d-8023-da9df389861d">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">25000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="51f8f206-6eb2-4436-a159-8ad2bae77758">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-17" />
      <value currency="USD" value-date="2021-09-17">-2468131.23</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f68db1d0-3cd1-4b04-9cc4-8d1e4392fb18">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-17" />
      <value currency="USD" value-date="2021-09-17">4478266.23</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0a84de16-6888-4e49-81f1-4ca529a9e375">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-23" />
      <value currency="USD" value-date="2021-09-23">68470.50</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4eb683dd-8da9-4e05-a027-6701af5e6d5a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-23" />
      <value currency="USD" value-date="2021-09-23">1012740.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cef9e2dd-3547-452d-8487-22154afeead7">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-07" />
      <value currency="USD" value-date="2021-10-07">100645.50</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fed7c701-9ee6-46ed-937f-9edf57eec9be">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">702378.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b8112c75-6812-4176-a012-a1493f145ad2">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-20" />
      <value currency="USD" value-date="2022-01-20">1300328.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="88d71294-a71d-44ca-9eaf-20d3ca7fda5b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-01" />
      <value currency="USD" value-date="2022-03-01">-25000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9e7e1761-ecbf-457b-80e8-c4f21f0db0d5">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-03-01" />
      <value currency="USD" value-date="2022-03-01">50000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0cc73379-4540-4147-8436-affe7ef3a1c4">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-18" />
      <value currency="USD" value-date="2022-03-18">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8cf35155-d38e-4c36-9c06-07cac460b50d">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-30" />
      <value currency="USD" value-date="2022-06-30">-1293704.23</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a1ad95b2-c740-42fa-aced-fab9aef76e78">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-30" />
      <value currency="USD" value-date="2022-06-30">1364950.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1313e86b-7c50-4551-a61a-f31108847db3">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-01" />
      <value currency="USD" value-date="2022-07-01">642739.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="758273ec-6087-4e4b-8b3b-d1e3d8d1c66e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-01" />
      <value currency="USD" value-date="2022-07-01">722211.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ed54d763-0241-496e-963f-807c950f8db6">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-19" />
      <value currency="USD" value-date="2022-11-19">4315891.88</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="86032ffd-adae-4496-8271-8b37239db3d1">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-22" />
      <value currency="USD" value-date="2022-11-22">1107709.64</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bc169b06-eb5e-46f5-abe9-daa93a22b961">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-22" />
      <value currency="USD" value-date="2022-11-22">209555.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5b3c0a1c-fca6-4306-9a1f-bb96988c35de">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-19" />
      <value currency="USD" value-date="2023-01-19">1187770.92</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6542a8bc-682d-4166-a067-318447bf73ca">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-01-19" />
      <value currency="USD" value-date="2023-01-19">849644.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="95b3afa5-d241-4ab7-9211-bef7916b33e6">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-21" />
      <value currency="USD" value-date="2023-03-21">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3c2ebcfc-0c1c-42bd-bb0f-d496df78d911">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-30" />
      <value currency="USD" value-date="2023-03-30">865890.32</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="616c15e8-19be-45b8-9d85-844d763d4138">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-30" />
      <value currency="USD" value-date="2023-03-30">95322.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e0889cef-6c8e-4a2f-8666-7617a9a15319">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-06-06" />
      <value currency="USD" value-date="2023-06-06">1355256.70</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c15b114b-fd9e-4dd4-a378-71d0d0c3e9c8">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-04" />
      <value currency="USD" value-date="2023-07-04">113549.75</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="50ab7a2d-3ef6-462d-9306-14ff9d486d63">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-23" />
      <value currency="USD" value-date="2023-07-23">25000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8a12ad8d-8262-432a-9e3e-f2158836b98f">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-11" />
      <value currency="USD" value-date="2023-09-11">1216706.95</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e3a4aaa5-f6ca-4a78-b84b-c0f9e5ca97c2">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-11" />
      <value currency="USD" value-date="2023-09-11">-1241706.95</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3ec3f994-6e76-4480-9551-9b516722d4b5">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-11" />
      <value currency="USD" value-date="2023-09-11">-25000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9f9500a7-f582-415c-a799-650943f48cab">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-14" />
      <value currency="USD" value-date="2023-09-14">420318.01</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d072fa1e-6143-46d6-b1be-d0fd63e3541e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-14" />
      <value currency="USD" value-date="2023-09-14">796388.94</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aac3ca35-8b5c-4549-acef-8f845b4f3a43">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-03" />
      <value currency="USD" value-date="2023-10-03">25000.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b183af35-6443-4931-a950-39cd40742030">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-29" />
      <value currency="USD" value-date="2024-01-29">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="25c84dc0-8e34-47ad-a677-ae7d0c20dcf1">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-13230.08</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5fbb7801-d530-438e-b184-3601821c27cd">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">13230.08</value>
      <description>
        <narrative>Funds returned to the Global Fund from QUA-C-UNDPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ce450bc4-b7b6-4e18-a8a7-f7d9045d8f64">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-12-13" />
      <value currency="USD" value-date="2024-12-13">373312.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from QUA-C-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="945e1a57-871a-43e1-8dfe-0e4b43d1e2fc">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-12-16" />
      <value currency="USD" value-date="2024-12-16">-373312.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="db786583-a569-42d5-8a49-099df2f6e688">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">-16874.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="667723cc-5e2c-492a-bb1f-f87e1f89bdb3">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">16874.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from QUA-C-UNDPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="QUA-C-UNDPP03-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">2415228.46</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for QUA-C-UNDPP03, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QUA-C-UNDPP03-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">4028218.79</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for QUA-C-UNDPP03, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QUA-C-UNDPP03-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">5310853.47</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for QUA-C-UNDPP03, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QUA-C-UNDPP03-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">905221.51</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for QUA-C-UNDPP03, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QUA-C-UNDPP03-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">262458.65</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for QUA-C-UNDPP03, Jul 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QUA-C-UNDPP03-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">162612.51</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for QUA-C-UNDPP03, Jan 2025 to Jun 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/QUA-C-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/QUA/Multicountry Western Pacific/2020/TB_HIV/en/QUA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 3 - TB/HIV - Oceania - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR870-MCWP-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-08-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 1160; Denominator: 9284; Percentage: 12.49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1160.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1197; Denominator: 9284; Percentage: 12.89%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1039; Denominator: 9284; Percentage: 11.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1234; Denominator: 9284; Percentage: 13.29%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1511; Denominator: 9284; Percentage: 16.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 824; Denominator: 1511; Percentage: 54.53%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 687; Denominator: 1511; Percentage: 45.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1; Denominator: 1511; Percentage: 0.07%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1510; Denominator: 1511; Percentage: 99.93%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1274; Denominator: 9284; Percentage: 13.72%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1545; Denominator: 9284; Percentage: 16.6%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 1364; Denominator: 3904; Percentage: 34.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1364; Denominator: 3904; Percentage: 34.94%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1668; Denominator: 3904; Percentage: 42.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1424; Denominator: 3904; Percentage: 36.48%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1553; Denominator: 3904; Percentage: 39.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 806; Denominator: 1553; Percentage: 51.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 747; Denominator: 1553; Percentage: 48.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1553; Denominator: 1553; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1490; Denominator: 3904; Percentage: 38.17%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1590; Denominator: 3904; Percentage: 40.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 818; Denominator: 1590; Percentage: 51.45%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 772; Denominator: 1590; Percentage: 48.55%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1590; Denominator: 1590; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1590; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 1910; Denominator: 18569; Percentage: 10.29%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1910.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1910.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1954; Denominator: 18569; Percentage: 10.52%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2270; Denominator: 18569; Percentage: 12.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2008; Denominator: 18569; Percentage: 10.81%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2279; Denominator: 18569; Percentage: 12.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1476; Denominator: 2279; Percentage: 64.77%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 803; Denominator: 2279; Percentage: 35.23%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1; Denominator: 2279; Percentage: 0.04%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 2278; Denominator: 2279; Percentage: 99.96%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2066; Denominator: 18569; Percentage: 11.13%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2326; Denominator: 18569; Percentage: 12.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1782; Denominator: 2326; Percentage: 76.61%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 544; Denominator: 2326; Percentage: 23.39%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2326; Denominator: 2326; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 0; Denominator: 2326; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="5" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="9" />
          <actual value="2" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="10" />
          <actual value="3" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="11" />
          <actual value="6" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="5" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="9" />
          <actual value="2" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="10" />
          <actual value="3" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="11" />
          <actual value="6" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 1472; Denominator: 9284; Percentage: 15.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 689.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 689.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 783.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 783.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1515; Denominator: 9284; Percentage: 16.32%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1600; Denominator: 9284; Percentage: 17.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1562; Denominator: 9284; Percentage: 16.82%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1568; Denominator: 9284; Percentage: 16.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 719; Denominator: 1568; Percentage: 45.85%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 849; Denominator: 1568; Percentage: 54.15%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1612; Denominator: 9284; Percentage: 17.36%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1724; Denominator: 9284; Percentage: 18.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1113; Denominator: 1724; Percentage: 64.56%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 611; Denominator: 1724; Percentage: 35.44%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 1369; Denominator: 3904; Percentage: 35.07%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 665.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 665.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 704.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 704.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1369.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1369.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1435; Denominator: 3904; Percentage: 36.76%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1833; Denominator: 3904; Percentage: 47%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1499; Denominator: 3904; Percentage: 38.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1585; Denominator: 3904; Percentage: 40.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 765; Denominator: 1585; Percentage: 48.26%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 820; Denominator: 1585; Percentage: 51.74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1585; Denominator: 1585; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1568; Denominator: 3904; Percentage: 40.16%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1590; Denominator: 3904; Percentage: 40.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 818; Denominator: 1590; Percentage: 51.45%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 772; Denominator: 1590; Percentage: 48.55%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1590; Denominator: 1590; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 2046; Denominator: 18569; Percentage: 11.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 736.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 736.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 1309.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 1309.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2101; Denominator: 18569; Percentage: 11.31%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2297; Denominator: 18569; Percentage: 12.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2159; Denominator: 18569; Percentage: 11.63%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2394; Denominator: 18569; Percentage: 12.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 856; Denominator: 2394; Percentage: 35.76%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 1538; Denominator: 2394; Percentage: 64.24%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2221; Denominator: 18569; Percentage: 11.96%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2541; Denominator: 18569; Percentage: 13.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1897; Denominator: 2541; Percentage: 74.66%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 644; Denominator: 2541; Percentage: 25.34%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 89.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 5.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 90.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 185.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 115.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 357.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 145.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 460.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 4; Denominator: 460; Percentage: 0.87%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 0; Denominator: 460; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 895.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 198.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 198.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 602.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 602.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 335.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 335.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 381.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 381.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 421.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 421.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 459.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 459.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 342.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 342.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 907.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 653.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 927.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 649.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 100; Denominator: 649; Percentage: 15.41%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 549; Denominator: 649; Percentage: 84.59%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 361; Denominator: 649; Percentage: 55.62%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 162; Denominator: 649; Percentage: 24.96%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 333; Denominator: 649; Percentage: 51.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 288; Denominator: 649; Percentage: 44.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 487; Denominator: 649; Percentage: 75.04%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 948.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1156.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 820; Denominator: 1156; Percentage: 70.93%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 336; Denominator: 1156; Percentage: 29.07%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 510; Denominator: 1156; Percentage: 44.12%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 550; Denominator: 1156; Percentage: 47.58%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 606; Denominator: 1156; Percentage: 52.42%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 656; Denominator: 1156; Percentage: 56.75%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 498; Denominator: 1156; Percentage: 43.08%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 2; Denominator: 1156; Percentage: 0.17%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="90.99">
          <comment>
            <narrative>Numerator: 899; Denominator: 988.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="68.63">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 617; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="68.63">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 617; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="21.91">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 197; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="21.91">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 197; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="47.61">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 428; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="47.61">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 428; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="42.94">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 386; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="42.94">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 386; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="29.14">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 262; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="29.14">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 262; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="61.4">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 552; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="61.4">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 552; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="0">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 0; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="0">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 0; Denominator: 899.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="91" />
          <actual value="83.2">
            <comment>
              <narrative>Numerator: 644; Denominator: 774.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="92" />
          <actual value="86.4">
            <comment>
              <narrative>Numerator: 566; Denominator: 655.</narrative>
            </comment>
          </actual>
          <actual value="15.02">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 85; Denominator: 566.</narrative>
            </comment>
          </actual>
          <actual value="84.98">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 481; Denominator: 566.</narrative>
            </comment>
          </actual>
          <actual value="77.03">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 436; Denominator: 566.</narrative>
            </comment>
          </actual>
          <actual value="22.79">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 129; Denominator: 566.</narrative>
            </comment>
          </actual>
          <actual value="48.23">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 273; Denominator: 566.</narrative>
            </comment>
          </actual>
          <actual value="51.06">
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 289; Denominator: 566.</narrative>
            </comment>
          </actual>
          <actual value="0.18">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1; Denominator: 566.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="93" />
          <actual value="85">
            <comment>
              <narrative>Numerator: 562; Denominator: 661.</narrative>
            </comment>
          </actual>
          <actual value="83.1">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 467; Denominator: 562.</narrative>
            </comment>
          </actual>
          <actual value="16.9">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 95; Denominator: 562.</narrative>
            </comment>
          </actual>
          <actual value="43.59">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 245; Denominator: 562.</narrative>
            </comment>
          </actual>
          <actual value="56.41">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 317; Denominator: 562.</narrative>
            </comment>
          </actual>
          <actual value="75.62">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 425; Denominator: 562.</narrative>
            </comment>
          </actual>
          <actual value="24.38">
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 137; Denominator: 562.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 0; Denominator: 562.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="80">
          <comment>
            <narrative>Numerator: 56; Denominator: 70.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 68; Denominator: 80.</narrative>
            </comment>
          </target>
          <actual value="97">
            <comment>
              <narrative>Numerator: 64; Denominator: 66.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="88.24">
            <comment>
              <narrative>Numerator: 75; Denominator: 85.</narrative>
            </comment>
          </target>
          <actual value="95.7">
            <comment>
              <narrative>Numerator: 66; Denominator: 69.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 81; Denominator: 90.</narrative>
            </comment>
          </target>
          <actual value="94.1">
            <comment>
              <narrative>Numerator: 64; Denominator: 68.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-QUA-C-UNDP-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Multi-country Western Pacific Integrated HIV/TB Program - Oceania - Multicountry Western Pacific (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Multicountry Western Pacific, TB/HIV, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To support 12 Pacific Island countries in ending AIDS and tuberculosis in the post-Covid period. Objectives: To strengthen comprehensiveness and quality of HIV prevention, treatment and care service-delivery models with a view to programmatic sustainability; To provide early rapid and quality diagnosis of TB, DR-TB and comorbidities with specific focus on hard to reach, vulnerable groups across 12 Pacific Island countries; To sustain high quality treatment for all forms of TB including drug-resistant TB and HIV-related TB with patient support; To build up the resilience of healthcare systems, including community systems, to deliver integrated people-centered models of HIV and TB care.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="QUA-C-UNDPP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Sandra Irbe</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>sandra.irbe@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="3" />
    <recipient-region code="MCWP" vocabulary="99" vocabulary-uri="https://fetch.theglobalfund.org/v5/odata/geographies" percentage="100">
      <narrative>Multicountry Western Pacific</narrative>
    </recipient-region>
    <sector vocabulary="1" code="12110" percentage="55.95">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="22.18">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="21.87">
      <narrative>HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="f8950f0e-59db-4839-9e56-5ad9689ca68d" percentage="0.59">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for AGYW and their male sexual partners programs</narrative>
        </description>
      </budget-item>
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="4.13">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="891c6028-9f9a-427f-8e25-55b502d52054" percentage="0.21">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing outside of KP and AGYW programs</narrative>
        </description>
      </budget-item>
      <budget-item code="d0aef99a-6d26-4e24-9937-7363cf44e158" percentage="0.42">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e41c9e1f-dfcd-4d62-9a3d-2c6d760bb3af" percentage="0.75">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="26ab57aa-470b-4e99-bff9-92e1452cf6cd" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="54f285ef-8db0-40b2-8052-f00a00522b8d" percentage="3.84">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
        </description>
      </budget-item>
      <budget-item code="3eb32c17-6380-4aa6-8a3b-73b4cb922dee" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Post-natal infant prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="698ea3f4-346f-4df8-ab2e-c01a47bbccd9" percentage="0.05">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Prevention of incident HIV among pregnant and breastfeeding women</narrative>
        </description>
      </budget-item>
      <budget-item code="8549b926-d8fb-4fa0-b3b8-79fc250303b6" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Comprehensive sexuality education for adolescent girls and young women (AGYW) and adolescent boys and young men (ABYM)</narrative>
        </description>
      </budget-item>
      <budget-item code="0a745960-07a1-46b7-add6-90d0e9ec5fd4" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; HIV prevention communication, information and demand creation for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="47ac0494-6213-481b-a81d-d00d7dca8f99" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Pre-exposure prophylaxis (PrEP) programming for male sexual partners of AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="0.03">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="0.91">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="0.14">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="e14e7a7d-49ce-4bb6-8454-ae4224e7a32e" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="52020c8d-d3b6-42f6-9137-038784523b8a" percentage="0.51">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Condom and lubricant programming for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="97e87d65-a4de-4357-81ae-2aae27b112a2" percentage="2.03">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; HIV prevention communication, information and demand creation for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="8a68b0fa-0674-4039-b5d0-396ae5bcf3d3" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Removing human rights-related barriers to prevention for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="d01264fd-1485-4b1a-b85c-fbaa2fa20933" percentage="0.94">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="394d6538-8808-4811-b96b-d6bf71843cb6" percentage="0.77">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="3f39233d-f679-42ce-8532-a7949f0d93ef" percentage="0.33">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="c1c1a139-7603-46fe-a10f-3766fac53456" percentage="0.18">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Community empowerment for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="daac344e-ec8e-4193-9c8a-266fdd2e69ac" percentage="0.06">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="55ece96e-d30c-46d2-8db0-27306b249434" percentage="0.91">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; HIV prevention communication, information and demand creation for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="ec84ef8b-ad12-46a3-9175-4f68245fa984" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="e6662a80-0f0d-4611-990c-6044696834dc" percentage="0.03">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy for human rights</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="0.36">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="39d71dad-c8af-467d-9fcc-8ac534b86784" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
        </description>
      </budget-item>
      <budget-item code="b745fdfb-055f-428b-9634-646cf15f5904" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="e0bd4666-bd16-440a-81d4-ded76d1d1b10" percentage="0.31">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
        </description>
      </budget-item>
      <budget-item code="530c3ad4-ec67-412e-9dc9-b83b6de6bf61" percentage="0.3">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced HIV disease (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="2.45">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="0.2">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="0.39">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="1.11">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="30.48">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="54ecd23c-7754-465c-a3f6-98604ccecebf" percentage="1.01">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Community health workers: In-service training</narrative>
        </description>
      </budget-item>
      <budget-item code="2eb956de-b42d-4ae1-b0a8-8ac53c3bbb5a" percentage="4.75">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Community health workers: contracting, remuneration and retention</narrative>
        </description>
      </budget-item>
      <budget-item code="9fa6654d-29f0-4b9e-9de9-674479de3110" percentage="0.67">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: In-service training (excluding community health workers)</narrative>
        </description>
      </budget-item>
      <budget-item code="5a6fc5ba-08a3-455c-887d-00867a865303" percentage="1.27">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Quality improvement and capacity building for quality of care</narrative>
        </description>
      </budget-item>
      <budget-item code="cd617bfe-5123-4888-8f4c-d3ff4f3eddce" percentage="7.25">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Remuneration and deployment of existing/new staff (excluding community health workers)</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="3.13">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="12d82614-1fc1-4696-b954-b899115b31d9" percentage="0.33">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="0.13">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="0.34">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="85fbea77-53b5-4647-bd23-d3053191c7bb" percentage="3.44">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveillance for HIV, tuberculosis and malaria</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="1.86">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="0.07">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="0.18">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="0.1">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="9.58">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="8.72">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="897b3d08-9a6f-4d26-89e2-f762e49dad11" percentage="0.98">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="2.1">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.42">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">3238691.67</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">3793556.74</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">3415944.44</value>
    </budget>
    <capital-spend percentage="0.67" />
    <transaction ref="95bea643-9754-4bd0-8c4b-d1c7e4affdbf">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-08" />
      <value currency="USD" value-date="2024-01-08">5813933.48</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="480cbd51-25fa-4125-aa1f-f6f6daee1c61">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-16" />
      <value currency="USD" value-date="2024-01-16">3738592.60</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5615e710-b0a6-4849-bbbd-a0ba4baff710">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-07" />
      <value currency="USD" value-date="2025-01-07">2069526.88</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f2587140-daae-4d32-80a3-d245aeb9bad1">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">16874.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a4163b39-7104-4997-b2c0-df563d0a254a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">16874.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="478c90a2-4d6b-4380-85c3-6baec638b8de">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-20" />
      <value currency="USD" value-date="2025-08-20">2353739.85</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fae70208-9447-4f0d-8905-23e91f8bfa35">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-20" />
      <value currency="USD" value-date="2025-08-20">-5814.00</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bab2e753-1034-40e8-9e78-0684b1584020">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-26" />
      <value currency="USD" value-date="2025-08-26">784579.95</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e9acecd3-fa47-4638-98c4-cb9464d64c56">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-07" />
      <value currency="USD" value-date="2025-10-07">737340.74</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c16f9d85-7278-4992-8312-09bb6b5a2dac">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-13" />
      <value currency="USD" value-date="2026-01-13">831819.16</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5d86b26e-bc97-4903-bf66-033e2389d03d">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-19" />
      <value currency="USD" value-date="2026-05-19">2070787.20</value>
      <description>
        <narrative>Global Fund commitment to QUA-C-UNDPP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ca529828-611b-479d-be9c-15df9775251d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-26" />
      <value currency="USD" value-date="2026-05-26">704410.20</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4707a6bf-4d41-4a0b-afbf-626e936a3ac0">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-03" />
      <value currency="USD" value-date="2026-11-03">1366377.00</value>
      <description>
        <narrative>Global Fund disbursement to QUA-C-UNDPP04 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="QUA-C-UNDPP04-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">3235413.17</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for QUA-C-UNDPP04, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="QUA-C-UNDPP04-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">3158259.63</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for QUA-C-UNDPP04, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/QUA-C-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/QUA/Multicountry Western Pacific/2023/TB_HIV/en/QUA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 2 - TB/HIV - Oceania - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1475-MCWP-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-05-30" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data. (1) Principles. Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with any law and/or policy applicable to it; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons. (3) The Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data. Prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any law or regulation applicable to the Principal Recipient.</narrative>
      </condition>
      <condition type="2">
        <narrative>2 - Under Article 3 of the UNDP-Global Fund Grant Regulations, the “Grant” consists of “funds as stated in the relevant Grant Confirmation together with any funds previously granted by the Global Fund to the Principal Recipient for the Program”. In this regard, please note that where the Global Fund has approved the use under the current Grant Confirmation of grant funds disbursed to the Principal Recipient under a previous Grant Agreement for the Program (“Previously Disbursed Grant Funds”), the Global Fund may reduce the amount of Grant Funds that remains uncommitted set forth in Section 3.6 of the Grant Confirmation by the amount of any Previously Disbursed Grant Funds, upon written notification to the Principal Recipient.</narrative>
      </condition>
      <condition type="2">
        <narrative>3 - To the extent consistent with and without prejudice to the Framework Agreement and, in particular, Article 2 of the UNDP-Global Fund Grant Regulations, the Principal Recipient shall be guided by the Global Fund Guidelines for Grant Budgeting (2023, as amended from time to time, available at the Global Fund’s Internet site) in the budgeting of the Grant.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="16.28">
          <comment>
            <narrative>Numerator: 1511; Denominator: 9284.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="17.77">
            <comment>
              <narrative>Numerator: 1914; Denominator: 10770.</narrative>
            </comment>
          </target>
          <actual value="17.37">
            <comment>
              <narrative>Numerator: 1871; Denominator: 10770.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="22.04">
            <comment>
              <narrative>Numerator: 2374; Denominator: 10770.</narrative>
            </comment>
          </target>
          <actual value="19.45">
            <comment>
              <narrative>Numerator: 2095; Denominator: 10770.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="22.66">
            <comment>
              <narrative>Numerator: 2440; Denominator: 10770.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="12.27">
          <comment>
            <narrative>Numerator: 2279; Denominator: 18569.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="19.97">
            <comment>
              <narrative>Numerator: 2400; Denominator: 12016.</narrative>
            </comment>
          </target>
          <actual value="15.77">
            <comment>
              <narrative>Numerator: 1895; Denominator: 12016.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="24.38">
            <comment>
              <narrative>Numerator: 2930; Denominator: 12016.</narrative>
            </comment>
          </target>
          <actual value="17.49">
            <comment>
              <narrative>Numerator: 2101; Denominator: 12016.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="25.37">
            <comment>
              <narrative>Numerator: 3048; Denominator: 12016.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="39.78">
          <comment>
            <narrative>Numerator: 1553; Denominator: 3904.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="35.37">
            <comment>
              <narrative>Numerator: 1685; Denominator: 4764.</narrative>
            </comment>
          </target>
          <actual value="34.55">
            <comment>
              <narrative>Numerator: 1646; Denominator: 4764.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="39.78">
            <comment>
              <narrative>Numerator: 1895; Denominator: 4764.</narrative>
            </comment>
          </target>
          <actual value="34.01">
            <comment>
              <narrative>Numerator: 1620; Denominator: 4764.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="44.4">
            <comment>
              <narrative>Numerator: 2115; Denominator: 4764.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="16.89">
          <comment>
            <narrative>Numerator: 1568; Denominator: 9284.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="18.71">
            <comment>
              <narrative>Numerator: 2015; Denominator: 10770.</narrative>
            </comment>
          </target>
          <actual value="16.51">
            <comment>
              <narrative>Numerator: 1778; Denominator: 10770.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="23.2">
            <comment>
              <narrative>Numerator: 2499; Denominator: 10770.</narrative>
            </comment>
          </target>
          <actual value="21.01">
            <comment>
              <narrative>Numerator: 2263; Denominator: 10770.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="23.84">
            <comment>
              <narrative>Numerator: 2568; Denominator: 10770.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="40.6">
          <comment>
            <narrative>Numerator: 1585; Denominator: 3904.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="37.24">
            <comment>
              <narrative>Numerator: 1774; Denominator: 4764.</narrative>
            </comment>
          </target>
          <actual value="34.55">
            <comment>
              <narrative>Numerator: 1646; Denominator: 4764.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="41.88">
            <comment>
              <narrative>Numerator: 1995; Denominator: 4764.</narrative>
            </comment>
          </target>
          <actual value="36.38">
            <comment>
              <narrative>Numerator: 1733; Denominator: 4764.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="46.73">
            <comment>
              <narrative>Numerator: 2226; Denominator: 4764.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for transgender people and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="12.89">
          <comment>
            <narrative>Numerator: 2394; Denominator: 18569.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="21.02">
            <comment>
              <narrative>Numerator: 2526; Denominator: 12016.</narrative>
            </comment>
          </target>
          <actual value="17.16">
            <comment>
              <narrative>Numerator: 2062; Denominator: 12016.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="25.67">
            <comment>
              <narrative>Numerator: 3084; Denominator: 12016.</narrative>
            </comment>
          </target>
          <actual value="19.62">
            <comment>
              <narrative>Numerator: 2358; Denominator: 12016.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="26.7">
            <comment>
              <narrative>Numerator: 3208; Denominator: 12016.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="1047" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="1138" />
          <actual value="1534" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="1210" />
          <actual value="1583" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="1283" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="52.24">
          <comment>
            <narrative>Numerator: 547; Denominator: 1047.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="80.05">
            <comment>
              <narrative>Numerator: 911; Denominator: 1138.</narrative>
            </comment>
          </target>
          <actual value="85.59">
            <comment>
              <narrative>Numerator: 1313; Denominator: 1534.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="85.04">
            <comment>
              <narrative>Numerator: 1029; Denominator: 1210.</narrative>
            </comment>
          </target>
          <actual value="64.88">
            <comment>
              <narrative>Numerator: 1027; Denominator: 1583.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90.02">
            <comment>
              <narrative>Numerator: 1155; Denominator: 1283.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="86" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="90" />
          <actual value="80.48">
            <comment>
              <narrative>Numerator: 1253; Denominator: 1557.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="91" />
          <actual value="76.43">
            <comment>
              <narrative>Numerator: 1174; Denominator: 1536.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="92" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="702" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="1710" />
          <actual value="1923" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="2276" />
          <actual value="1361" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="3085" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="30.64">
          <comment>
            <narrative>Numerator: 634; Denominator: 2069.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="33.99">
            <comment>
              <narrative>Numerator: 891; Denominator: 2621.</narrative>
            </comment>
          </target>
          <actual value="22.22">
            <comment>
              <narrative>Numerator: 1372; Denominator: 6176.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="37">
            <comment>
              <narrative>Numerator: 1074; Denominator: 2903.</narrative>
            </comment>
          </target>
          <actual value="31.25">
            <comment>
              <narrative>Numerator: 1863; Denominator: 5962.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-12-31" />
          <target value="39.99">
            <comment>
              <narrative>Numerator: 1278; Denominator: 3196.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>